These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33350279)

  • 1. [Post-marketing intensive safety monitoring of Injection of Xuesaitong (lyophilized) in 30097 cases].
    Xin-Yao J; Ke-Yi W; Jing-Bo Z; Chun-Xiang L; Hui W; Zhi L; Wen-Tai P; Hu-Cheng W; Nan LI; Jun-Hua Z; Wen-Ke Z
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):5029-5033. PubMed ID: 33350279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of Injection of Xuesaitong (lyophilized) in 30097 cases in real world].
    Xin-Yao J; Ke-Yi W; Jing-Bo Z; Chun-Xiang L; Hui W; Zhi L; Wen-Tai P; Hu-Cheng W; Nan LI; Hui-Zi C; Jun-Hua Z; Wen-Ke Z
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):5024-5028. PubMed ID: 33350278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of the Xuesaitong injection in China: results from a large-scale multicentre post-marketing surveillance study in a real-world setting.
    He Y; Gao XM; Li L; Liu XG; Liu W; Hong XJ; Huang BH; Yang HL; Xue MH; Wu XJ; Liu JF
    Curr Med Res Opin; 2020 Dec; 36(12):1947-1953. PubMed ID: 33016133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical safety studies based on 30 026 post-marketing cases of Shenqi Fuzheng injection by intensive hospital monitoring nested NCCS].
    Wang LX; Xie YM; Ai QH; Xu WF
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4739-45. PubMed ID: 27245015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intensive hospital monitoring of Shuxuening injection in 30 209 cases].
    Jiang JJ; Xie YM; Zhang Y; Li MQ; Zhao YB; Wen ZH; Li XL; Yi DH; Zhang YK
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2883-2888. PubMed ID: 29139252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital].
    Li X; Tang J; Meng F; Li C; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2783-5. PubMed ID: 22292364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of Xuesaitong injection combined with western medicines in the treatment of ischemic stroke: an updated systematic review and meta-analysis.
    Feng L; Wu XJ; Cao T; Wu B
    Ann Palliat Med; 2021 Sep; 10(9):9523-9534. PubMed ID: 34628878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-marketing safety surveillance of Diemailing Kudiezi injection: real world study in 30 233 cases].
    Liao X; Yu DD; Xie YM; Zhang YL; He Y; Zhang Y; Liu Y; Yi DH; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2857-2863. PubMed ID: 29139248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations.
    Wang C; Shi QP; Ding F; Jiang XD; Tang W; Yu ML; Zhu JH
    Drug Des Devel Ther; 2018; 12():757-767. PubMed ID: 29670332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-marketing safety surveillance and re-evaluaiton of Shu-Xue-Ning injection: a real-world study based on 30,122 cases.
    Xinyao J; Yifan Z; Keyi W; Wentai P; Chunyang W; Hui W; Chunxiang L; Yunhua X; Wenke Z
    Front Pharmacol; 2023; 14():1194367. PubMed ID: 38094887
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-marketing safety monitoring of shenqifuzheng injection: a solution made of dangshen (Radix Codonopsis) and huangqi (Radix Astragali Mongolici).
    Ai Q; Zhang W; Xie Y; Huang W; Liang H; Cao H
    J Tradit Chin Med; 2014 Aug; 34(4):498-503. PubMed ID: 25185371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of adverse reactions' factors to Danhong injection--nested case control study by using hospital centralized monitoring data].
    Ji MM; Li CX; Tang JF; Zhang QL; Xu T; Yu YN; Liu J; Yang W; Yang WB; Wang Z; Jing ZW; Li XL
    Zhongguo Zhong Yao Za Zhi; 2018 Apr; 43(8):1714-1719. PubMed ID: 29751721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retrospective analysis and discussion on 74 cases of adverse reactions of traditional Chinese medicine injection].
    Wang Y; Fan LP; Song J; Cai YP; Jinang TT; Wang YG; Kong XW; Wu JR
    Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4347-4351. PubMed ID: 30583639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expert consensus on clinical application of Lixuwang~® Xuesaitong Soft Capsules].
    Jia M; Liang X; Fu GJ; Jin XL; Lu Y; Liao X; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5668-5674. PubMed ID: 38114160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [32 546 intensive hospital monitoring cases of Shuxuetong injection].
    Jiang JJ; Xie YM; Zhang Y; Yang ZX; Yi DH
    Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(20):3852-3858. PubMed ID: 28929666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical comprehensive evaluation of Ginkgolide Injection in treatment of cerebral infarction].
    Liu FM; Xie YM; Wang ZF; Zhang Q; Cui X
    Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1493-1500. PubMed ID: 35347948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Ornidazole Injection in Clinical Use at Post-marketing Stage by Centralized Hospital Monitoring System.
    Zhao Y; Chen Z; Huang P; Zheng SW; Xu QL; Shi C
    Curr Med Sci; 2019 Oct; 39(5):836-842. PubMed ID: 31612405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Post-marketing study on clinical safety of ginkgo diterpene lactone meglumine injection in 6 300 patients with ischemic stroke].
    Zhou L; Gao Y; Lai XX; Xu TS; Yu M; Wang Y; Zhao JJ; Tan ZH
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4744-4749. PubMed ID: 29493141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of the Xuesaitong soft capsule in the treatment of patients with ischemic stroke: systematic review and meta-analysis.
    Gao Y; Chen Z; Li X; Cai Y; Gao F; Tang Y; Ran W
    Ann Palliat Med; 2022 Aug; 11(8):2695-2708. PubMed ID: 36064360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reevaluation of the post-marketing safety of Xuebijing injection based on real-world and evidence-based evaluations.
    Wang C; Shi QP; Ding F; Jiang XD; Tang W; Yu ML; Cheng JQ
    Biomed Pharmacother; 2019 Jan; 109():1523-1531. PubMed ID: 30551404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.